Skip to main content
International Journal of Experimental Pathology logoLink to International Journal of Experimental Pathology
. 1992 Oct;73(5):593–601.

Lactic dehydrogenase virus infection prevents development of anti-nuclear antibody in (NZB x NZW)F1 mice; role of prostaglandin E2 and macrophage Ia antigen expression.

T Hayashi 1, I Mori 1, H Yamamoto 1
PMCID: PMC2002009  PMID: 1419777

Abstract

Persistent lactic dehydrogenase virus (LDV) infection prevents the development of antinuclear antibody (ANA) in (NZB x NZW)F1 mice. To assess the suppressive mechanisms, we focused on the role of the E series of prostaglandin(PGE), since previously we have shown enhanced production of PGE by macrophages from chronically LDV-infected mice. Treatment with PGE2 suppressed ANA titres more markedly in non-infected mice than in LDV-infected mice. Indomethacin enhanced ANA titres more markedly in LDV-infected mice than in non-infected mice. The number of Ia antigen positive(Ia+) macrophages was less in LDV-infected mice than in uninfected mice. The number of Ia+ macrophages was decreased in non-infected mice by PGE2 treatment and increased in LDV-infected mice by indomethacin treatment. These results suggest that the low ANA production in LDV-infected (NZB x NZW)F1 mice may be related to the decreased number of Ia+ macrophages and that one of the factors responsible for suppression of Ia+ macrophages may be the enhanced PGE2 production in the LDV-infected mice.

Full text

PDF
593

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelman N. E., Watling D. L., McDevitt H. O. Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies. J Exp Med. 1983 Oct 1;158(4):1350–1355. doi: 10.1084/jem.158.4.1350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bonney R. J., Naruns P., Davies P., Humes J. L. Antigen-antibody complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal macrophages. Prostaglandins. 1979 Oct;18(4):605–616. doi: 10.1016/0090-6980(79)90027-3. [DOI] [PubMed] [Google Scholar]
  3. Donnelly R. P., Levine J., Hartwell D. Q., Frendl G., Fenton M. J., Beller D. I. Aberrant regulation of IL-1 expression in macrophages from young autoimmune-prone mice. J Immunol. 1990 Nov 15;145(10):3231–3239. [PubMed] [Google Scholar]
  4. Hartung H. P., Schäfer B., Heininger K., Toyka K. V. Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase. Ann Neurol. 1988 May;23(5):453–460. doi: 10.1002/ana.410230505. [DOI] [PubMed] [Google Scholar]
  5. Hayashi T., Ozaki M., Ami Y., Onodera T., Yamamoto H. Increased superoxide anion release by peritoneal macrophages in mice with a chronic infection of lactic dehydrogenase virus. J Comp Pathol. 1992 Jan;106(1):93–98. doi: 10.1016/0021-9975(92)90073-4. [DOI] [PubMed] [Google Scholar]
  6. Hayashi T., Ozaki M., Mori I., Saito M., Itoh T., Yamamoto H. Enhanced clearance of lactic dehydrogenase-5 in severe combined immunodeficiency (SCID) mice: effect of lactic dehydrogenase virus on enzyme clearance. Int J Exp Pathol. 1992 Apr;73(2):173–181. [PMC free article] [PubMed] [Google Scholar]
  7. Hayashi T., Salata K., Kingman A., Notkins A. L. Regulation of enzyme levels in the blood. Influence of environmental and genetic factors on enzyme clearance. Am J Pathol. 1988 Sep;132(3):503–511. [PMC free article] [PubMed] [Google Scholar]
  8. Heremans H., Billiau A., Coutelier J. P., De Somer P. The inhibition of endotoxin-induced local inflammation by LDH virus or LDH virus-infected tumors is mediated by interferon. Proc Soc Exp Biol Med. 1987 May;185(1):6–15. doi: 10.3181/00379727-185-42509. [DOI] [PubMed] [Google Scholar]
  9. Hirano T., Taga T., Yasukawa K., Nakajima K., Nakano N., Takatsuki F., Shimizu M., Murashima A., Tsunasawa S., Sakiyama F. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci U S A. 1987 Jan;84(1):228–231. doi: 10.1073/pnas.84.1.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Inada T., Mims C. A. Infection of mice with lactic dehydrogenase virus prevents development of experimental allergic encephalomyelitis. J Neuroimmunol. 1986 Mar;11(1):53–56. doi: 10.1016/0165-5728(86)90074-3. [DOI] [PubMed] [Google Scholar]
  11. Isakov N., Feldman M., Segal S. Acute infection of mice with lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of their macrophages. Cell Immunol. 1982 Jan 15;66(2):317–332. doi: 10.1016/0008-8749(82)90182-4. [DOI] [PubMed] [Google Scholar]
  12. Jacob C. O., McDevitt H. O. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature. 1988 Jan 28;331(6154):356–358. doi: 10.1038/331356a0. [DOI] [PubMed] [Google Scholar]
  13. Kelley V. E., Winkelstein A., Izui S. Effect of prostaglandin E on immune complex nephritis in NZB/W mice. Lab Invest. 1979 Dec;41(6):531–537. [PubMed] [Google Scholar]
  14. Kowalchyk K., Plagemann P. G. Cell surface receptors for lactate dehydrogenase-elevating virus on subpopulation of macrophages. Virus Res. 1985 Apr;2(3):211–229. doi: 10.1016/0168-1702(85)90010-3. [DOI] [PubMed] [Google Scholar]
  15. McDonald T. L. Isolation of Clq-binding virus-antibody immune complexes from lactic dehydrogenase virus (LDV)-infected mice. Immunology. 1982 Feb;45(2):365–370. [PMC free article] [PubMed] [Google Scholar]
  16. NOTKINS A. L. LACTIC DEHYDROGENASE VIRUS. Bacteriol Rev. 1965 Jun;29:143–160. doi: 10.1128/br.29.2.143-160.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Notkins A. L., Mahar S., Scheele C., Goffman J. Infectious virus-antibody complex in the blood of chronically infected mice. J Exp Med. 1966 Jul 1;124(1):81–97. doi: 10.1084/jem.124.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Oldstone M. B., Dixon F. J. Inhibition of antibodies to nuclear antigen and to DNA in New Zealand mice infected with lactate dehydrogenase virus. Science. 1972 Feb 18;175(4023):784–786. doi: 10.1126/science.175.4023.784. [DOI] [PubMed] [Google Scholar]
  19. Rokutan K., Hosokawa T., Nakamura K., Koyama K., Aoike A., Kawai K. Increased superoxide anion production and glutathione peroxidase activity in peritoneal macrophages from autoimmune-prone MRL/Mp-Ipr/lpr mice. Int Arch Allergy Appl Immunol. 1988;87(2):113–119. doi: 10.1159/000234660. [DOI] [PubMed] [Google Scholar]
  20. Satoh J., Seino H., Shintani S., Tanaka S., Ohteki T., Masuda T., Nobunaga T., Toyota T. Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-alpha. J Immunol. 1990 Sep 1;145(5):1395–1399. [PubMed] [Google Scholar]
  21. Snyder D. S., Beller D. I., Unanue E. R. Prostaglandins modulate macrophage Ia expression. Nature. 1982 Sep 9;299(5879):163–165. doi: 10.1038/299163a0. [DOI] [PubMed] [Google Scholar]
  22. Snyder D. S., Unanue E. R. Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol. 1982 Nov;129(5):1803–1805. [PubMed] [Google Scholar]
  23. Stenson W. F., Parker C. W. Prostaglandins, macrophages, and immunity. J Immunol. 1980 Jul;125(1):1–5. [PubMed] [Google Scholar]
  24. Wilson C. A., Jacobs C., Baker P., Baskin D. G., Dower S., Lernmark A., Toivola B., Vertrees S., Wilson D. IL-1 beta modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J Immunol. 1990 May 15;144(10):3784–3788. [PubMed] [Google Scholar]
  25. Wofsy D., Seaman W. E. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med. 1985 Feb 1;161(2):378–391. doi: 10.1084/jem.161.2.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Zurier R. B., Damjanov I., Sayadoff D. M., Rothfield N. F. Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis. Arthritis Rheum. 1977 Nov-Dec;20(8):1449–1456. doi: 10.1002/art.1780200802. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES